•An anticoagulant used to prevent and treat deep vein thrombosis

•  Binds to and accelerates the activity of antithrombin III and thus potentiates inhibition of coagulation factors Xa and lia.

• Its anticoagulant effect can be directly correlated to its ability to inhibit factor Xa which catalyzes the conversion of prothrombin to thrombin, inhibition of this process results in decreased thrombin and ultimately the prevention of fibrin clot formation.

• Preventing blood clots in patients who having certain types of surgery.

•Also used along with other medicine to treat blood clots and heart attack.

• As effective as unfractionated heparin in the prevention of thromboembolic events in patients with heart failure or severe respiratory disease..

• As effective as unfractionated heparin in the prevention of thromboembolic events in patients with heart failure or severe respiratory disease.’

• Subcutaneous enoxaparin 20mg once daily for 10 days is as effective and well tolerated as subcutaneous unfractionated heparin 5000 IU twice daily in the prevention of venous thromboembolic disease.”